MINNEAPOLIS & CHICAGO--(BUSINESS WIRE)--An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant® Thoracic Stent Graft System from Medtronic, Inc. (NYSE: MDT), delivered excellent clinical results th
Medtronic Inc. Posted on:19 Jun 11 An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant® Thoracic Stent Graft System from Medtronic, Inc. (NYSE: MDT), delivered excellent clinical results through
The Brain Aneurysm Foundation has announced the recipients of its annual research grants. In 2011, The Foundation will award $160,000 in grants to eight individuals conducting scientific research directed at early detection, improved treatment modalities,
For many patients, cholesterol-lowering statin drugs can reduce the risk of strokes as well as heart attacks. But Loyola University Health System neurologists caution that statins may not be appropriate for certain categories of patients who are at-risk f
For many patients, cholesterol-lowering statin drugs can reduce the risk of strokes as well as heart attacks. But in a review article, Loyola University Health System neurologists caution that statins may not be appropriate for cetain categories of patien